Biotech ETFs tumble as Celgene’s quarterly results and outlook weigh
October 26, 2017 at 10:24 AM EDT
Exchange-traded funds that track the biotechnology sector sink on Thursday, following weak quarterly results from a major component.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.